Company’s Analyst Day showcases its priorities
Market for cell-culture chemistry analyzers on moderate upswing
IBO Indexes push forward despite political uncertainties
Latest sales, operating income and net profit figures for analytical and life science instrument and laboratory product companies
FDA makes landmark decision in drug approval
Budget reduces science funding and threatens cap on percentage of NIH grants allocated for indirect costs
President discloses ownership talks
Cytogenetics and NGS reagents attract Sysmex
Company invests in SAAS solutions
Japanese firms combine capabilities
Pay Invoice
Latest Blogs
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.